Stay updated on Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial

Sign up to get notified when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:56:38.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in a medical and healthcare-related publication or documentation regarding a Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:36.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age ranges and health conditions required for inclusion, as well as exclusion criteria for the clinical trial.
    Difference
    21%
    Check dated 2024-05-22T21:29:19.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:31:51.000Z thumbnail image

Stay in the know with updates to Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.